Redmile Group, LLC
10% Owner; Director, 10% Owner · 3 filings · Latest: Apr 20, 2026
ADC Therapeutics SA
FATE THERAPEUTICS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADCT | Redmile Group, LLC | 10% Owner | Apr 2, 2026 | Sale | $3.28 | 5,163,997 | $16.9M | 10,265,297 | |
ADCT | Redmile Group, LLC | 10% Owner | Apr 1, 2026 | Sale | $3.80 | 331,782 | $1.3M | 12,794,788 | |
ADCT | Redmile Group, LLC | 10% Owner | Mar 31, 2026 | Sale | $3.75 | 384,636 | $1.4M | 12,957,305 | |
FATE | Redmile Group, LLC | — | Dec 20, 2024 | Proposed Sale | $1.66 | 341,633 | $567.1K | — | |
STTK | Redmile Group, LLC | — | Dec 4, 2024 | Proposed Sale | $1.13 | 133,371 | $150.7K | — |